logo
These Are The Plug-In Hybrids The EPA Says Can Go The Distance On Battery Power

These Are The Plug-In Hybrids The EPA Says Can Go The Distance On Battery Power

Forbes02-07-2025
The 2025 Mercedes-Benz GLC 350e beats all plug-in hybrids with a battery-only range of 54 miles, ... More after which it's only limited by the amount of gas in the tank.
While the majority of U.S. motorists are still hesitant to make the switch to a full electric car for a variety of reasons, those who still want to minimize both their fuel consumption and carbon footprint would find a plug-in hybrid electric vehicle (PHEV) to be an amenable compromise.
Like standard hybrids, PHEVs augment a gasoline engine with one or more electric motors to produce energetic acceleration on a fuel-frugal basis, but go a step further by packing a larger battery that allows them to operate for extended periods solely (and silently) on electricity. Once the battery charge is depleted to a certain point, the vehicle continues to operate as a conventional hybrid under a combination of gas and electric power. In both modes energy that would otherwise be lost from deceleration and stopping are recovered and sent back to the battery via a process called regenerative braking.
PHEVs eliminate many of the negatives associated with full-electric cars, especially what's come to be known as range anxiety. That's because regardless of the battery's state of charge, a PHEV's ultimate operating range is limited only by the amount of fuel remaining in the tank. That makes them more viable than EVs for taking extended road trips, with gas stations being far more plentiful (and in good working order) across the nation than public EV charging stations. Plus, a PHEV owner needn't have a 240-volt (Level 2, in EV lingo) electrical service installed in the garage, as most are able to charge-up overnight using a standard 110-volt (Level 1) outlet.
The best PHEV cars and SUVs afford enough charge to cover an average driver's daily commute just on battery power, which according to the U.S. Department of Transportation, is 31.8 miles round trip. That means those with modest daily needs may only rarely have to visit a gas station for a fill-up.
The range-topper for 2025 is the Mercedes-Benz GLC350e all-wheel-drive plug-in hybrid SUV with a 54-mile electric-only range. According to the EPA that translates into the electric equivalent of 64 miles per gallon in combined city/highway driving. In hybrid mode it gets a still-decent 25 mpg, though it requires premium-grade fuel. The PHEV faring the best in terms of kilowatt and gas consumption is the Toyota Prius Plug-In that's EPA-rated at a whopping 127 MPGe on battery power for its 45-mile electric-only range, and 52 MPG while driving in hybrid mode.
We've compiled a list below of the 25 PHEVs that are EPA-rated to be driven for an average of the first 32 miles on a charge, which as noted above, is sufficient for an average motorist's daily commute. We're also noting the estimated 'MPGe' fuel economy equivalent for each model while running on battery power, and the combined city/highway mileage when running in gas/electric hybrid mode.
Of course, the only way for a PHEV to reach its full potential is to be tethered to the grid when not in use. Studies have shown that somewhere between 30% and 50% of PHEV owners neglect to charge their vehicles regularly. This can be attributed to a number of factors that include having to rely on street parking, limited access to public charging, a lack of understanding regarding the technology or just plain laziness.
To paraphrase the 1960's counter-culturalist Timothy Leary, 'Plug in, turn on, drive off.'
Plug-In Hybrids With The Longest Battery-Only Range
These are the 25 PHEVs from the 2025 model year that are EPA-rated to tackle the average daily commute – and much more with the class leaders ­– solely on battery power and with zero tailpipe emissions. We're noting both their equivalent miles per gallon while running on electricity (MPGe) and their conventional fuel economy ratings while running on hybrid power; those with an asterisk (*) require premium-grade fuel.
Source: EPA.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Beeline Holdings Inc (BLNE) Q2 2025 Earnings Call Highlights: Strategic Divestment and Revenue ...
Beeline Holdings Inc (BLNE) Q2 2025 Earnings Call Highlights: Strategic Divestment and Revenue ...

Yahoo

time10 minutes ago

  • Yahoo

Beeline Holdings Inc (BLNE) Q2 2025 Earnings Call Highlights: Strategic Divestment and Revenue ...

Release Date: August 14, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Beeline Holdings Inc (NASDAQ:BLNE) successfully divested its spirits assets, allowing a full focus on its core digital mortgage lending business. The company reported a 27% increase in revenue and a 40% decrease in expenses in Q2 2025 compared to Q1 2025. Beeline Holdings Inc (NASDAQ:BLNE) introduced a new equity product that is not tied to interest rates, providing a competitive advantage. The AI sales agent, Bob, significantly improved lead conversion and mortgage application rates, contributing approximately $150,000 in revenue. The company reduced its debt by $6.2 million in 2025, aiming to be debt-free by November 1, 2025, and cash flow positive by January 2026. Negative Points The market remains challenging due to higher interest rates affecting refinance and purchase transactions. The company reported a net loss from continuing operations of $4 million for Q2 2025. There were $500,000 in one-time non-recurring expenses in Q2, impacting financial results. The broader launch of the new equity product has been delayed to ensure proper execution and customer satisfaction. Despite improvements, the company still faces significant scaling challenges and uncertainties in its new product offerings. Q & A Highlights Warning! GuruFocus has detected 5 Warning Signs with BLNE. Q: Can you provide more details about the home equity cash-out product and the timing of its broader launch? A: (Nick Lauza, CEO) We initially planned to launch in late August or early September but decided to delay to ensure we get it right. The opportunity is massive, with untapped equity in the US market. The Genius Act provides regulatory clarity, and we want to ensure the product is perfect before scaling. We will conduct a select number of transactions over the next 30 to 45 days to gather feedback and ensure consumer interests are prioritized. Q: What are the assumptions behind your profitability projections for late this year or early next year? A: (Nick Lauza, CEO) We are focusing on achieving profitability quickly by cutting $225,000 in monthly recurring expenses, which will be fully realized by September. Our locks are up, and we've reduced our marketing budget by $40,000 monthly while maintaining strong performance. We also had $500,000 in one-time expenses in Q2, which won't recur. We aim to be debt-free by November 1 and cash flow positive by January 2026. Q: Can you explain the economics of the fractional products and the expected volume at scale? A: (Nick Lauza, CEO) Our margins will be higher than our mortgage products, with less work involved since we're underwriting the property, not the consumer. We expect about 33% more revenue per file. Marketing expenses will be minimal as our partner will drive the business. We've identified about 1,000 potential customers who would qualify for this product. Q: What will drive significant growth in 2026, even without rate cuts? A: (Nick Lauza, CEO) We expect strong demand for Beeline Equity, as it provides liquidity based on home equity rather than individual qualifications. This product is ideal for those who can't qualify for cash-out refis or HELOCs. Additionally, our mortgage business is improving, and we have a strong title business team. We anticipate the equity product to be our largest revenue generator in 2026, followed by the mortgage and title businesses. Q: Do you have a sensitivity analysis for how rate cuts could impact growth? A: (Nick Lauza, CEO) While we don't have specific figures, a 25 basis point cut would significantly impact our business as a centralized digital lender. Digital models perform better in low-rate environments, and a 1-point cut would lead to rapid growth. (Chris Moe, CFO) Additionally, the longer rates remain high, the more significant the impact of a cut due to pent-up demand. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Intel's Frankfurt-listed shares rise 3.6% after report US could take stake in chipmaker
Intel's Frankfurt-listed shares rise 3.6% after report US could take stake in chipmaker

Yahoo

time10 minutes ago

  • Yahoo

Intel's Frankfurt-listed shares rise 3.6% after report US could take stake in chipmaker

LONDON (Reuters) -Intel's Frankfurt-listed shares rose 3.6% on Friday, a day after Bloomberg News reported the Trump administration is in talks with the struggling chipmaker to have the U.S. government potentially take a stake in the company. Intel's U.S. shares surged more than 7% in regular trading Thursday and then another 2.6% after the bell. Intel on Thursday declined to comment on the report. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Blood pressures rise as the FDA cracks down on this wearable's flagship feature
Blood pressures rise as the FDA cracks down on this wearable's flagship feature

Android Authority

time12 minutes ago

  • Android Authority

Blood pressures rise as the FDA cracks down on this wearable's flagship feature

WHOOP TL;DR The FDA has scrutinized Whoop for a new wellness monitoring feature that has not been certified. The FDA considers the Whoop MG (Medical Grade) a medical device and should remove the Blood Pressure Insights feature until approved. Whoop claims the product is not for medical use and will not disable the feature. Wellness wearable maker Whoop, specifically one of its latest fitness bands, has drawn the ire of the FDA after it debuted a feature not approved or certified by the authority. Per a Bloomberg filing, the FDA is pressuring Whoop to disable its Blood Pressure Insights feature. This new app offers its wearers blood pressure estimates and related guidance to provide a holistic view of their well-being. However, the FDA and Whoop can't seem to agree whether the MG's feature constitutes a medical device and must go through the traditional regulatory channels. WHOOP Whoop's marketing material claims that the MG is 'not a medical device and cannot diagnose or manage medical conditions,' and, as a result, the FDA has no authority to 'regulate the product.' However, the FDA seemingly believes otherwise, claiming that potentially erroneous blood pressure readings can harm those wearing the device. Regardless, Whoop reportedly has confirmed that it would not remove the feature, going against the recent trends of health tech firms relenting to the agency. Don't want to miss the best from Android Authority? Set us as a preferred source in Google Search to support us and make sure you never miss our latest exclusive reports, expert analysis, and much more. Medical devices must go through the relevant FDA channels for testing and approval before being marketed and sold; this includes unproven and novel sensors on smartwatches and fitness trackers. While the process ensures consumers are offered clinically-approved products, it can take months, often resulting in features launching well after a device has debuted. The Fitbit Sense's ECG sensor is a particularly memorable example of this. The FDA can demand fines from offending companies or even forbid their products from being sold. Still, the genuine issue appears to be the nebulous definitions of medical devices and modern fitness trackers. We've seen wellness wearable makers debut numerous features in recent years, but blood pressure readings and guidance remain relatively novel. The Samsung Galaxy Watch line and Garmin products like the Index include similar features, but both Korean and American companies have undergone the relevant approval processes before launch. Despite its firm stance, Whoop has reportedly requested an audience with the FDA to clarify the situation, but it's unclear how this tussle will ultimately affect Whoop MG owners. The screenless wellness band debuted for $359 alongside the Whoop 5.0 in May, but the Blood Pressure Insights feature is available only to premium subscribers. Follow

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store